Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Respiratory Hypersensitivity
Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker.
Laughter
Elimination pathways of [14C]losoxantrone in four cancer patients.
Bioflavonoid luteolin prevents sFlt-1 release via HIF-1a inhibition in cultured human placenta.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Bioflavonoid luteolin prevents sFlt-1 release via HIF-1a inhibition in cultured human placenta.
Bioflavonoid luteolin prevents sFlt-1 release via HIF-1a inhibition in cultured human placenta. FASEB J. 2023 08; 37(8):e23078.
View in:
PubMed
subject areas
Female
Humans
Luteolin
Placenta
Pre-Eclampsia
Pregnancy
Proto-Oncogene Proteins c-akt
Receptor Protein-Tyrosine Kinases
Trophoblasts
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factor Receptor-1
authors with profiles
Sarosh Rana